Radiation may spare early rectal cancer patients from radical surgery

NCT ID NCT07695519

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This observational study follows about 196 adults with early-stage (pT1) rectal cancer who have high-risk features after local tumor removal. Instead of undergoing radical surgery that often requires a colostomy, participants receive adjuvant radiotherapy or chemoradiotherapy. The study tracks cancer recurrence, quality of life, and whether the organ-sparing approach is effective over three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
adjuvant radiotherapy or chemoradiotherapy
What this could lead to
If successful, this study could show that adding radiotherapy after local tumor removal is a safe alternative to radical surgery, helping patients avoid a permanent colostomy.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. The risk of cancer recurrence remains, and radiotherapy has its own side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, RM, 00168, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.